Prospection of Novel Coronavirus Covid-2019 Proteins and Bioinformatic Potential in Search of New Promising Drugs

Authors

DOI:

https://doi.org/10.9771/cp.v13i2.36008

Keywords:

COVID-2019, Prospection, Docking Molecular.

Abstract

COVID-2019 disease, caused by the 2019-nCOV virus or SARS-Cov-2, adds up to just over 290 thousand cases and 12 thousand deaths worldwide. No clinical studies are indicating effective treatments, and the identification of suitable antiviral agents is a crucial step in combating the pandemic. This research constitutes a survey of SARS-Cov-2 proteins from the Protein Data Bank (PDB), eligible as targets for docking of inhibitory substances. later, in silico tests were performed with two enzymatic targets in interaction with the drugs Ledipasvir and Ombitasvir. Prospecting in the PDB reported 29 proteins. 6vsb and 6m17 were selected for docking with Ledispasvir, resulting in interaction energies equal to -6.88 and -6.25kJ / mol, respectively. For the same targets, the drug Ombitasvir obtained -5.96 and -4.53kJ / mol. The study showed the advances in COVID-19 research, presenting 29 structures. The drugs tested showed favorable parameters for continuing in vitro and clinical studies.

Downloads

Download data is not yet available.

Author Biographies

Ruan Sousa Bastos, Federal University of Para

Graduated in Natural Sciences/Chemistry from the Federal University of Maranhão - UFMA, Campus de Grajaú. Master's student in Medicinal Chemistry and Molecular Modeling - UFPA. Participated in the Institutional Scholarship Program for Teaching Initiation - PIBID and in the Pedagogical Residency Program. Member of the Research Group on Medicinal Chemistry and Biotechnology - QUIMEBIO and member of the Research Group on Natural Sciences and Biotechnology - CIENATEC. He works in the lines of Biotechnology and Computational Quantum Chemistry.

Jefferson Santos Oliveira, Federal University of Maranhão

postgraduate student in Materials Science at the Federal University of Maranhão (PPGCM-UFMA). Degree in Chemistry from the Federal Institute of Education, Science and Technology of Maranhão (IFMA). Current line of research consists of synthesis of organic crystals and characterization by X-Ray Diffraction, Raman Spectroscopy, and Thermal Analysis. He was a Scientific Initiation Scholar in the area of ​​microbiology, where he investigated the contamination of Staphylococcus in milk sold informally in Açailândia-MA. Still as a Scientific Initiation student, he studied the potential of steel residues (blast furnace slag and balloon dust) as agricultural correctives. He was also a volunteer in the Institutional Scholarship Program for Initiation to Teaching (PIBID), in which he developed pedagogical activities in a high school in Açailandia MA, and studied the use of concept maps for the revision of the High School Chemistry curriculum.

Marcelo Henrique Vilhena da Silva, Federal Institute of Education, Science and Technology of Pará

He holds a degree in Full Degree in Chemistry from the Federal Institute of Education, Science and Technology of Pará (2004), a degree in dentistry from the Federal University of Pará (2011) and a master's degree in Mechanical Engineering from the Federal University of Pará (2018). He is currently an ebtt professor at the Federal Institute of Education, Science and Technology of Pará. Has experience in Chemistry, with emphasis on Corrosion, Teaching, Environmental Chemistry.

Francisco das Chagas Alves Lima, Universidade Estadual do Piau

Graduated in Full Licentiate in Chemistry from the Federal University of Piauí (2002), Master's from the University of São Paulo (2004). PhD from the University of São Paulo at the São Carlos Institute of Chemistry (2008).

Jefferson Almeida Rocha, Federal University of Maranhão

Graduated in Biological Sciences from the State University of Piauí - UESPI where he participated in the microbiology research group - LABMICRO. Specialization in Environmental Management from Faculdade Latinoamericana de Educação - FLATED, with emphasis on Water Resources. Master in Biotechnology from the Federal University of Piauí - UFPI. Doctor in Biotechnology by the Northeast Biotechnology Network - RENORBIO. Leader/Founder of the Research Group in Natural Sciences and Biotechnology - CIENATEC at UFMA/Campus de Grajaú. He is currently an Adjunct Professor at the Federal University of Maranhão - UFMA, Campus de São Bernardo, Permanent Member of the Professional Master's Degree in Intellectual Property and Network Technology Transfer (PROFNIT/UFMA) and Permanent Member of the Graduate Program in Biotechnology - PPGBiotec, at Master's level at the Federal University of Delta do Parnaíba - UFDPAR. It operates in the lines of Biotechnology, Medicinal Chemistry, Computational Quantum Chemistry, Bioinformatics, Bioprospecting of bioactive extracts, Research against Neglected Diseases and Intellectual Property and Innovation.

References

ANDREI, César Cornélio et al. Da Química Medicinal à química combinatória e modelagem molecular-um curso prático. Barueri: Editora Manole, 2003.

BARREIRO, Eliezer J.; FRAGA, Carlos Alberto Manssour. Química Medicinal: as bases moleculares da ação dos fármacos. São Paulo: Artmed, 2014.

BASTOS, R. S. Estudo prospectivo, química quântica computacional e atividade antibacteriana in vitro do complexo di-µ-cloro-bis [cloro (4,7-dimetil-1, 10-fenantrolina) cádmio (ii)]. 2019. 117f. Monografia (Graduação Ciências Naturais – Química) – Universidade Federal do Maranhão, UFMA, Grajaú, 2019.

BRASIL. Coronavírus: 18 mortes e 1.128 casos confirmados. Brasília: Ministério da Saúde, 2020. Disponível em: https://www.saude.gov.br/noticias/agencia-saude/46571-coronavirus-18-mortes-e-1-128-casos-confirmados. Acesso em: 22 fev. 2020.

CENTRE FOR ARBOVIRUS DISCOVERY, DIAGNOSIS. First cases of coronavirus disease (COVID-19) in Brazil, South America (2 genomes, 3rd March 2020). [S.l: s.n.], [2020]. Disponível em: http://virological.org/t/first-cases-of-coronavirus-disease-covid-19-in-brazil-south-america-2-genomes-3rd-march-2020/409. Acesso em: 23 mar. 2020.

CSIZMADIA, Peter. Marvin Sketch and MarvinView: molecule applets for the World Wide Web, 1999.

CUI, J.; LI, F.; SHI, Z. L. Origem e evolução dos coronavírus patogênicos. Nat. Rev. Microbiol., [S.l.], n. 17, p. 181-192, 2019.

FRISCH, M. J. et al. Gaussian 09. Wallingford CT: Gaussian, Inc., 2009.

DONG, Liying; HU, Shasha; GAO, Jianjun. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discoveries & Therapeutics, [S.l.], v. 14, n. 1, p. 58-60, 2020. Disponível em: https://doi.org/10.5582/ddt.2020.01012. Acesso em: 23 mar. 2020.

GAGNÉR, Viktor Ahlberg et al. Clustering of atomic displacement parameters in bovine trypsin reveals a distributed lattice of atoms with shared chemical properties. Scientific Reports, [S.l.], v. 9, n. 1, p. 1-14, 2019. Disponível em: https://doi.org/10.1038/s41598-019-55777-5. Acesso em: 23 mar. 2020.

HUI, D. S. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China - International Journal of Infectious Diseases. International Journal of Infectious Diseases, [S.l.], v. 91, n. PG, p. 264-266, Fev. 2020. Disponível em: https://doi.org/10.1016/j.ijid.2020.01.009. Acesso em: 23 mar. 2020.

JIN, Zhenming et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. bioRxiv, [S.l.], 29 mar. 2020. Disponível em: https://doi.org/10.1101/2020.02.26.964882. Acesso em: 23 mar. 2020.

KATZUNG, Bertram G.; TREVOR, Anthony J. Farmacologia Básica e Clínica-13. São Paulo: McGraw Hill Brasil, 2017.

KUMARI, Radhika; NGUYEN, Mindie H. Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1. Expert opinion on pharmacotherapy, [S.l.], v. 16, n. 5, p. 739-748, 2015. Disponível em: https://doi.org/10.1517/14656566.2015.1013938. Acesso em: 23 mar. 2020.

LEE, Ting-Wai et al. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. Journal of molecular biology, [S.l.], v. 353, n. 5, p. 1.137-1.151, 2005. Disponível em: https://doi.org/10.1016/j.jmb.2005.09.004. Acesso em: 23 mar. 2020.

MORRIS, G. M. et al. AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility. Journal of Computational Chemistry, [S.l.], v. 30, p. 2.785-2.791, 2009. Disponível em: https://doi.org/10.1002/jcc.21256. Acesso em: 23 mar. 2020.

PROTEIN DATA BANK (PDB). [2020]. Disponível em: http://www.rcsb.org/pdb/. Acesso em: 19 mar. 2020.

ROCHA, Jefferson A. et al. Computational quantum chemistry, molecular docking, and ADMET predictions of imidazole alkaloids of Pilocarpus microphyllus with schistosomicidal properties. PloS one, [S.l.], v. 13, n. 6, 2018. Disponível em: https://doi.org/10.1371/journal.pone.0198476. Acesso em: 23 mar. 2020.

STEWART, James J. P. Optimization of parameters for semiempirical methods V: modification of NDDO approximations and application to 70 elements. Journal of Molecular modeling, [S.l.], v. 13, n. 12, p. 1.173-1.213, 2007. Disponível em: https://doi.org/10.1007/s00894-007-0233-4. Acesso em: 23 mar. 2020.

WALLS, Alexandra C. et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, [S.l.], 9 de março de 2020. Disponível em: https://doi.org/10.1016/j.cell.2020.02.058. Acesso em: 23 mar. 2020.

WANG, Manli et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell research, [S.l.], v. 30, n. 3, p. 269-271, 2020. Disponível em: https://doi.org/10.1038/s41422-020-0282-0. Acesso em: 23 mar. 2020.

WORLD HEALTH ORGANIZATION. Novel Coronavirus (COVID-19) Situation Dashboard. [2020]. Disponível em: https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd. Acesso em: 22 fev. 2020.

WRAPP, Daniel et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science, [S.l.], v. 367, n. 6.483, p. 1.260-1.263, 2020. Disponível em: https://doi.org/10.1126/science.abb2507. Acesso em: 23 mar. 2020.

YAN, Renhong et al. Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2. Science, [S.l.], v. 367, Issue 6485, p. 1.444-1.448, 27 Mar. 2020. Disponível em: https://doi.org/10.1126/science.abb2762. Acesso em: 23 mar. 2020.

ZHU, Na et al. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine, [S.l.], n. 382, p. 727-733, 20 Feb. 2020. Disponível em: https://doi.org/10.1056/NEJMoa2001017. Acesso em: 23 mar. 2020.

Downloads

Published

2020-04-16

How to Cite

Bastos, R. S., Sousa, C. S. ., Oliveira, J. S. ., Silva, M. H. V. da ., Lima, F. das C. A., & Rocha, J. A. . (2020). Prospection of Novel Coronavirus Covid-2019 Proteins and Bioinformatic Potential in Search of New Promising Drugs. Cadernos De Prospecção, 13(2), 347. https://doi.org/10.9771/cp.v13i2.36008

Issue

Vol. 13 No. 2 (2020): Edição Especial - Coronavírus (SARS-COV-2) e COVID-19

Section

Coronavirus (SARS-COV-2) e COVID-19

License

Copyright (c) 2020 Cadernos de Prospecção

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

O autor declara que: - Todos os autores foram nomeados. - Está submetendo o manuscrito com o consentimento dos outros autores. - Caso o trabalho submetido tiver sido contratado por algum empregador, tem o consentimento do referido empregador. - Os autores estão cientes de que é condição de publicação que os manuscritos submetidos a esta revista não tenham sido publicados anteriormente e não sejam submetidos ou publicados simultaneamente em outro periódico sem prévia autorização do Conselho Editorial. - Os autores concordam que o seu artigo ou parte dele possa ser distribuído e/ou reproduzido por qualquer forma, incluindo traduções, desde que sejam citados de modo completo esta revista e os autores do manuscrito. - Revista Cadernos de Prospecção está licenciado com uma Licença Creative Commons Attribution 4.0. Esta licença permite que outros remixem, adaptem e criem a partir do seu trabalho para fins não comerciais, e embora os novos trabalhos tenham de lhe atribuir o devido crédito e não possam ser usados para fins comerciais, os usuários não têm de licenciar esses trabalhos derivados sob os mesmos termos. Licença Creative Commons
Este obra está licenciado com uma Licença Creative Commons Atribuição 4.0 Internacional.